Showing posts with label Fountain of youth. Show all posts
Showing posts with label Fountain of youth. Show all posts

Monday, April 3, 2017

Harvard scientist claims NMN drug has knocked 20 years off his age, and given his 77 year old father the energy of a 30 year old


A professor of genetics at Harvard Medical School has spent two decades investigating how to ‘cure’ aging and believes NMN is by far the best prospect of providing the answer.

His fountain of youth is actually a specialised variant of vitamin B3 that is found in many foods, including broccoli, cucumber and avocado, that helps our cells repair damaged DNA. The latter is believed to be a major cause of natural aging.

In the body, NMN is converted into a related chemical called nicotinamide adenine dinucleotide (NAD), which is found in every cell of living organisms and is essential for life. NAD is crucial in fuelling the seven different genes in our body that govern aging. However, our NAD levels decline by about 50 per cent as we age, turning off the body’s defenses against aging and age-related diseases such as cancer, diabetes, heart disease and Alzheimer’s.

Experiments on mice by Professor Sinclair and his team showed that after just a week of being fed NMN dissolved in their drinking water, the cells of aging mice were indistinguishable from those of young mice. Their muscles looked and behaved like those of a young mouse, too.

In human terms, it was the equivalent of a 60-year-old’s cells and muscles transforming into those of a 20-year-old. According to the team’s paper in the international journal Science, the mice suffered no negative side-effects.

Often what works brilliantly in lab mice doesn’t translate to the more complex systems of humans. However, Professor Sinclair says no one has ever tried to replace our dwindling NAD before.

‘NAD is a naturally occurring molecule in the body, so we’re really just replenishing what’s been lost over time,’ he says. ‘That’s different to other strategies that have introduced a foreign molecule from a bacterium or a plant, which could have all sorts of side-effects.

‘This is the closest we are to a safe and effective anti-ageing drug that’s perhaps only three to five years from being on the market if the trials go well.’

The first tests on humans will soon begin in Boston in the U.S., focusing first on safety and then on whether the treatment can actually reverse aging in people, too. They will be monitored closely by the U.S. space agency NASA, which is interested in using the drug during future missions to Mars to stop the accelerated aging process that affects astronauts exposed to radiation in space.

Professor Sinclair is so convinced of his pill’s safety that not only has he been taking it himself, so has his 77-year-old father.

The results certainly sound encouraging. Before he started taking a 500mg NMN pill every morning, 47-year-old Professor Sinclair had his blood tested and was told his body had a biological age of 58.

After consuming NMN for three months, he was tested again and his biological age was 32.

As for his father, he’s recently been out-pacing the professor’s younger brother on mountaineering expeditions in their native Australia.

‘He’s as vigorous as he was in his 20s and 30s, and he seems to be getting more energetic,’ says Professor Sinclair.

The manufacturing process of the NMN pill is complicated and expensive, and it currently costs Professor Sinclair more than $1,000 (£797) a month to buy it just for himself. Large-scale manufacturing would bring the cost down, but he says that ultimately it won’t be cheap. Of course it won’t — if it lives up to the hype, then it really is the long-sought-after elixir of youth.

We each have our own image of what it might entail, and taking a pill with my Bran Flakes is certainly not what I had in mind.

I mention Ursula Andress bathing in mystical cold flames that kept her forever young and gorgeous in the 1960s film version of the H. Rider Haggard story She.

Professor Sinclair remembers it, too. Nothing like that is quite on the cards, he admits… at least not yet.

For a start, what his NMN pill cannot do is rejuvenate our exterior appearance — especially if we’re already old.

The fact that Professor Sinclair, a father of three young children, still has no grey hairs and very few wrinkles seems a miracle in itself, but he suggests it isn’t because of his pills.



Hair loss, grey hair and wrinkled skin are not yet reversible, he says, although if you start taking NMN young, it may delay visible aging, as it’s much easier to prevent hair loss and grey hair than reverse it.

‘I don’t think people will go from 80 to looking like they are 20, although a person who started taking it in their 40s could stay looking in their 40s for longer.

‘What I am expecting is that their body’s internal workings will function better and people will be better protected against diseases as they get older,’ he explains.

And yet all is not lost for Ursula Andress wannabes. Stem cell replacement — the field that could rejuvenate skin and hair — is still in its infancy, but is looking hopeful, he says.

Professor Sinclair mentions Samumed, a California research company whose backers include the venture capitalist arm of IKEA and which claims considerable success in reversing the cosmetic aspects of aging.

By reprogramming genes to be younger, it is developing molecules that could restore hair and hair colour and remove skin wrinkles.

Another drug could even regenerate cartilage in the knees of arthritis patients.

Professor Sinclair, a molecular biologist by training who sold his first research company to British drugs giant GlaxoSmithKline for $720 million and who was in Time magazine’s 2014 list of the world’s 100 most influential people, is certainly not a lone voice.

There’s a growing scientific consensus that ageing is not inevitable.

There’s considerable disagreement, however, over to what extent the inevitable can be put off. A minority, so-called ‘immortalists’ — who are big on imagination but short on serious scientific credentials — believe we can avoid death indefinitely.

They include Aubrey de Grey, a British technology expert and thinker who reckons we can live for 1,000 years.

Then there’s the American futurist, Ray Kurzweil, who believes that humans will eventually physically merge with artificial intelligence and transcend our biological limitations.

Finally, there’s Martine Rothblatt, a transgender woman and one of America’s highest-paid chief executives, who intends to grow new organs from people’s DNA.

She has already commissioned a ‘back-up version’ of her own wife — a robot which has been uploaded with the real woman’s thoughts, memories and even feelings.

Aging science is a world full of quacks and charlatans, but that hasn’t stopped Silicon Valley billionaires and celebrities terrified by the thought of death from plunging vast sums into scientifically dubious projects.

A recent Los Angeles meeting to discuss the latest theories brought together the actress Goldie Hawn, pop star Moby and Google co-founder Sergey Brin, who has talked of ‘curing death’.

More serious scientists, including Professor Sinclair, are relatively modest in their ambitions: they speak of adding at most a few extra decades to our lifespans. But what’s possibly more important, they say, is improving our ‘health-spans’.

For what’s the use of having another 50 years to live, if you have to spend it in a wheelchair, crippled by arthritis?

Professor Sinclair has strong personal reasons for devoting his career to unlocking the secrets of aging.

He was in the middle of studying for his PhD when his mother contracted lung cancer. And he vividly recalls his sense of outrage watching his once vibrant grandmother grow old, enfeebled and pass away. It’s a tragic story being played out in everybody’s family, so why aren’t we up in arms about aging, he asks.

The answer, he knows, is because we regard aging as inevitable. In fact, everyone believed that until scientists identified genes that control DNA repair, and therefore the ageing process, in the Nineties.

It was known that strenuous exercise and a low-calorie diet put stress on our cells, prompting them to produce more NAD and so build up their defences against the sort of damage that will age us.

But we learned that over-exercising and starving ourselves is damaging, too, especially for older people — and so scientists intensified their search for a drug that could mimic their effect.

It was Professor Sinclair who initially identified a possible candidate in resveratrol, an antioxidant found in tiny amounts in red wine and in cocoa which reversed aging in mice.

Complicated to manufacture, difficult to administer and of limited effectiveness, resveratrol was not the miracle it had appeared. And so his search for a far more powerful substance led him to NMN.

As to what exactly it may do for us, he mentions strengthened endurance and fitness, enhanced energy, and muscles and organs such as the liver that will function more like they did when we were much younger. (If DNA damage is repaired or minimised, our organs don’t have a shelf life as such.) An increased metabolism might lead to weight loss, too.

Serious aging researchers are wary of being too specific on how many extra years their discoveries may give us, but given what it’s done for mice, Professor Sinclair’s estimate that NMN could buy us an extra five or ten years of healthy life sounds a little disappointing.

But it’s only a start, he insists. Combined with other research that scientists are doing around the world, our age span could be extended by half again.

‘I’ve stated before that the first person to live to 150 has already been born, and that’s me projecting where we’ll be [scientifically] 50 years from now,’ he says.

‘I don’t think we’re going to be immortal, but there’s no law of biology that says we can’t live for 200 years.’

What are these other areas of research? Professor Sinclair mentions two more promising drugs. One is metformin, a drug used to treat diabetes, which has been found to help some diabetics live longer than non-diabetics.

The other is rapamycin, derived from a fungus found on Easter Island in the Pacific Ocean and used to prevent organ transplant rejection. Tests have shown it suppresses the onset of cancer in mice. Both of these drugs, like NMN, trick our body into upping its defences against diseases and negative effects of aging.

The market for an effective anti-aging drug has been estimated at $26 billion a year.

However, Professor Sinclair and his team must first convince regulators to accept that aging is a treatable condition — essential if they want NMN officially approved as a drug — before the floodgates can open to the millions who may want to buy it.

In the meantime, many may ask whether we want to live until we’re 150 and — just as important — whether the world can cope if we do.

Critics of extending human lifespans warn that it will impose a crippling burden on healthcare and the global economy. But Professor Sinclair believes the opposite, arguing that it’s economically essential that we find a way of keeping the elderly healthy and productive.

‘We’re talking about people in their 90s playing tennis and educating their great-grandkids,’ he says.

‘It’ll be a totally different world where your 80s and 90s will be the equivalent of your 60s and 70s now.’

And from work with laboratory mice and observations of the very elderly, it seems death when it comes will be much more rapid, possibly after a short illness such as pneumonia. Scientists call this phenomenon the ‘compression of morbidity’.

Professor Sinclair says he thinks about the ethics of his work every day. What bothers him most is the idea that he could be sentencing people in unpleasant, unrewarding jobs to decades more misery as they struggle towards a far later retirement.

In the developed world, we’re well past the Bible’s approximation of the human lot of threescore years and ten — even without molecular tinkering.

Advances in medical and pharmaceutical technology, and improving lifestyles, mean that lifespans will continue to extend for much of the world’s population.

The prospect of a pill to boost longevity further still is a very good reason for our children, at least, to start looking forward to that 120th birthday party.

Tuesday, November 15, 2016

Does teenage BLOOD hold the key to the fountain of youth?


Life-extension advocates could be one step closer to the ‘biological fountain of youth’ – a treatment in which the blood of the young and healthy is used to reverse the effects of aging.

In a series of new trials, researchers have found that injecting the blood plasma of 18-year-old humans into old mice rejuvenates both the body and brain, improving cognition and allowing them to frolic about like their younger counterparts.

According to Alkahest, the company behind the experiments, blood plasma may hold the secrets to youth, and a similar technique could one day be used in procedures for humans.

The findings were presented at the Society for Neuroscience annual meeting in San Diego, California.

The firm, whose mission ‘is to enrich the health and vitality of humankind through transformative therapies that counterbalance the aging process,’ injected 12-month-old mice with blood samples from 18-year-old humans twice a week for three weeks.

At 12-months, mice have entered a stage roughly equivalent to that of a 50-year-old person, moving more slowly and performing badly on memory tests.

But, after three weeks, the researchers noted improvements in the mice’s performance on a range of tests.

Following the injections, the older mice were better at remembering their way around a maze – and, they ran around an open space like the younger group.

The results were compared to young, 3-month-old mice, and older mice who had not been given the treatment.

The researchers also examined the brains of the treated mice, and found that they appeared to have created new cells in the hippocampus.

This process, known as neurogenesis, is thought to contribute to memory and learning, and the results now show that it can be enhanced through the injection of young human blood, New Scientist reports.

According to Sakura Minami, of Alkahest, some of the factors that give young blood its power have now been identified – but, the team will not reveal them yet.

The researchers say these findings could one day help them to develop anti-aging treatments, and could even help people with Alzheimer’s disease.

Human trails have already begun to test this hypothesis.

Peter Thiel

In recent years, the bizarre practice has caught the attention of many life-extension enthusiasts – including billionaire tech investor Peter Thiel, who said he is looking into 'parabiosis.'

Early studies have shown that the transfusion of blood plasma from a young donor can have age-reversing effects on the body, and it's recently begun clinical trials on humans.

Human trials were launched recently by a company called Ambrosia, with participants paying $8,000 to get involved, according to Inc.

In the study, ‘Young Donor Plasma Transfusion and Age-Related Biomarkers,’ healthy individuals aged 35 or older receive a transfusion of blood plasma from donors younger than 25.

And, the firm has been contacted by Thiel Capital’s chief medical officer, Jason Camm, Inc. reports, who expressed interest in the work.

In an interview last year with Jeff Bercovici, Peter Thiel explained his interest in life-extension medicine.

Moving on from a discussion on caloric restriction, human growth hormone, and diabetes drug metformin, the investor said he isn’t yet convinced that scientists have found the cure-all technique.

But, he’s turned his sights to some ‘strangely underexplored’ fields.

‘I’m looking into parabiosis stuff, which I think is really interesting,’ Thiel told Bercovici.

‘This is where they did the young blood into older mice and they found that had a massive rejuvenating effect.’

Thiel went on to clarify that the procedure was of interest as a personal-health treatment, and said it would not require FDA approval.

Still, the investor remarked then that he hadn’t ‘quite, quite, quite started yet’ in moving forward with parabiosis, and according to Inc., this is still the case.

Scientists first experimented with parabiosis in the 1950s, and in recent years, it’s begun to gain attention once again.

In the organ systems of both animals and humans, the procedure has been found to reverse the symptoms of aging, though scientists don’t yet understand all of the mechanisms at work.

Jesse Karmazin, founder of Ambrosia, explains to Inc. that the blood of a young organism is rich with proteins that improve cell function, and can spur the production of these proteins in the recipient’s body.

And, the researcher says this effect appears to be ‘almost permanent.’


Also read:

Wednesday, July 27, 2016

Do Easter Island's statues hold the secrets of the fountain of youth?


It’s been nearly 50 years since scientists first discovered the natural drug hiding within the soil at Easter Island, and now, it’s been hailed by some as the ‘fountain of youth.’

The drug - rapamycin - is a bacterial by-product found in the shadows of the island's famous statues, and has shown to increase lifespan or improve some of the conditions related to aging. These ‘anti-aging’ capabilities have been demonstrated across a range of organisms, from fruit flies and mice, to dogs and even humans.

Rapamycin is named after Rapa Nui, the Polynesian name for Easter Island, which sits isolated in the Pacific Ocean. The soil containing rapamycin was first collected in 1964 by Georges Nógrády, a microbiologist from the University of Montreal. But, this wasn’t the object of the expedition, so the compound itself wasn’t discovered until five years later when the samples were analyzed by scientists at Ayerst Pharmaceutical, Chemical & Engineering News reports.

In 1969, these researchers discovered the powerful immunosuppressant which targets a protein called mTOR, a ‘central hub for nutrient signalling,’ and can stop cancer cells from dividing. Since then, scientists have unravelled far more information on the drug, finding it could help to fight solid tumors, and can prevent organ rejection in transplant patients.

The compound, which binds the proteins FKBP12 and mTOR, blocks the activity of mTORC1, which coordinates nutrient information, according to C&EN.

Later studies on yeast, nematode worms, and fruit flies determined that suppressing the activity of mTOR extended lifespan.

And in a 2009 study, it was found that administering rapamycin to fully grown mice led longer lives in both males and females – an extra six months for male mice, 9% longer than those without the drug, and 14% longer in females.

The drug has since been tested on marmosets, and even humans.


These trials have yielded some positive results, showing improvements in certain aspects of aging, including learning and cognitive function in humans, along with response to the flu vaccine, and proteostasis in marmosets, the maintenance of proteins.

Recently, it was revealed that scientists from the University of Washington are testing the effects of rapamycin on dogs to see if it will slow down the aging process. Researchers were shocked by results of the initial trials, which were revealed this past May, finding that some dogs showed improved heart functionality after just a few weeks.

The study is led by biologist Matt Kaeberlein and his colleague, Daniel Promislow. According to Fusion, the researchers began clinical trials this year.

Dogs age very quickly compared to a human lifespan; most live between 10 and 13 years. This allows researchers to study the entire aging process in a short amount of time.

The team recruited 40 dog-owners, who were each to give their pets three tablets of rapamycin a week, Fusion reports.

After the researchers weeded out dogs with heart conditions and other medical factors, they were left with 24 middle-aged dogs, who would each receive low doses of the drug. This continued over the course of 10 weeks, and the researchers took echocardiograms throughout to determine any changes in the animal’s heart function.

The team discovered that dogs receiving rapamycin showed improved heart functionality, or showed no change. Those who had come in with worse conditions initially saw the most improvement.

But, as research on the ‘fountain of youth’ drug continues, scientists warn that it isn’t yet clear if mTOR inhibitors are safe for long-term use. Rapamycin’s immune system-suppressing capabilities also mean it could leave its user susceptible to infection, scientists warn.

Now, many are working to develop compounds that don’t have a negative effect on the immune system.

‘It’s not optimized for what we want – which is treating disease or slowing aging,’ Brian Kennedy, president and chief executive officer of the Buck Institute for Research on Aging told C&EN, ‘but it’s pretty darn good at what it does, and if we can tweak it in ways that make it better, I think there’s a really exciting opportunity.’


Also read: